BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 7778826)

  • 1. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.
    Pearson DC; May GR; Fick GH; Sutherland LR
    Ann Intern Med; 1995 Jul; 123(2):132-42. PubMed ID: 7778826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2010 Jun; (6):CD000545. PubMed ID: 20556747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
    Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
    Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine for maintaining remission of Crohn's disease.
    Pearson DC; May GR; Fick G; Sutherland LR
    Cochrane Database Syst Rev; 2000; (2):CD000067. PubMed ID: 10796482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000478. PubMed ID: 17253451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
    Gisbert JP; Gomollón F; Maté J; Pajares JM
    Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
    [No Abstract]   [Full Text] [Related]  

  • 12. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis].
    Ohno K; Masunaga Y; Ogawa R; Hashiguchi M; Ogata H
    Yakugaku Zasshi; 2004 Aug; 124(8):555-60. PubMed ID: 15297725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease.
    O'Brien JJ; Bayless TM; Bayless JA
    Gastroenterology; 1991 Jul; 101(1):39-46. PubMed ID: 2044925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease].
    Bastida Paz G; Nos Mateu P; Aguas Peris M; Beltrán Niclós B; Rodríguez Soler M; Ponce García J
    Gastroenterol Hepatol; 2007 Nov; 30(9):511-6. PubMed ID: 17980127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
    Jacobstein DA; Baldassano RN
    Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy for inducing and maintaining remission in pouchitis.
    Sandborn W; McLeod R; Jewell D
    Cochrane Database Syst Rev; 2000; (2):CD001176. PubMed ID: 10796613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide for induction of remission in Crohn's disease.
    Otley A; Steinhart AH
    Cochrane Database Syst Rev; 2005 Oct; (4):CD000296. PubMed ID: 16235274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
    Hyams JS
    Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.